PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 26847636-4 2016 The use of radionuclide molecular imaging would enable non-invasive repeatable determination of EGFR expression in disseminated cancer. Radioisotopes 11-23 epidermal growth factor receptor Homo sapiens 96-100 9329625-8 1997 The results show that the anti-EGF-R-antibody (Mab 425) alone is not effective enough for therapeutical use, but it could be of clinical value in conjugation with radionuclides (e.g. I-131) in order to reach metastases not metabolizing iodine. Radioisotopes 163-176 epidermal growth factor receptor Homo sapiens 31-36 26847636-7 2016 In the present study, an EGFR-binding affibody molecule (ZEGFR:2377) was site-specifically conjugated with a deferoxamine (DFO) chelator and labelled under mild conditions (room temperature and neutral pH) with a positron-emitting radionuclide (89)Zr. Radioisotopes 231-243 epidermal growth factor receptor Homo sapiens 25-29 18265976-0 2008 Therapy of human carcinoma xenografts with antibodies to EGFr and HER-2 conjugated to radionuclides emitting low-energy electrons. Radioisotopes 86-99 epidermal growth factor receptor Homo sapiens 57-61 25931452-7 2015 The anti-EGFR antibody cetuximab has been labeled with various radionuclides and has been tested as an imaging biomarker in several HNSCC models. Radioisotopes 63-76 epidermal growth factor receptor Homo sapiens 9-13 22228543-1 2012 High expression of epidermal growth factor receptor (EGFR)-family receptors, especially EGFR, HER2, and HER3, makes them interesting for targeted radionuclide-based imaging and therapy of disseminated cancer. Radioisotopes 146-158 epidermal growth factor receptor Homo sapiens 19-51 22228543-1 2012 High expression of epidermal growth factor receptor (EGFR)-family receptors, especially EGFR, HER2, and HER3, makes them interesting for targeted radionuclide-based imaging and therapy of disseminated cancer. Radioisotopes 146-158 epidermal growth factor receptor Homo sapiens 53-57 22228543-1 2012 High expression of epidermal growth factor receptor (EGFR)-family receptors, especially EGFR, HER2, and HER3, makes them interesting for targeted radionuclide-based imaging and therapy of disseminated cancer. Radioisotopes 146-158 epidermal growth factor receptor Homo sapiens 88-92 21834651-4 2011 This study assesses the biodistribution of a novel human epidermal growth factor (hEGF) radionuclide conjugate after preinjection with anti-EGFR affibody molecules. Radioisotopes 88-100 epidermal growth factor receptor Homo sapiens 140-144 21834651-10 2011 These findings show that preblocking with an anti-EGFR affibody molecule is a promising tool that could improve the outcome of radionuclide-based imaging of EGFR-expressing tumors. Radioisotopes 127-139 epidermal growth factor receptor Homo sapiens 50-54 21834651-10 2011 These findings show that preblocking with an anti-EGFR affibody molecule is a promising tool that could improve the outcome of radionuclide-based imaging of EGFR-expressing tumors. Radioisotopes 127-139 epidermal growth factor receptor Homo sapiens 157-161 18202792-11 2008 The stability in the EGFR expression is encouraging in the effort to develop radionuclide-based EGFR imaging agents. Radioisotopes 77-89 epidermal growth factor receptor Homo sapiens 96-100 11096240-1 2000 OBJECTIVES: Overexpression of the epidermal growth factor receptor (EGFR) has been reported in bladder cancer and is a potential target for therapy with radionuclides. Radioisotopes 153-166 epidermal growth factor receptor Homo sapiens 34-66 18202792-11 2008 The stability in the EGFR expression is encouraging in the effort to develop radionuclide-based EGFR imaging agents. Radioisotopes 77-89 epidermal growth factor receptor Homo sapiens 21-25 17671674-13 2007 The stability in EGFR expression is encouraging for efforts to develop radionuclide based EGFR imaging agents. Radioisotopes 71-83 epidermal growth factor receptor Homo sapiens 17-21 17671674-13 2007 The stability in EGFR expression is encouraging for efforts to develop radionuclide based EGFR imaging agents. Radioisotopes 71-83 epidermal growth factor receptor Homo sapiens 90-94 17979785-0 2007 Cancer molecular imaging: radionuclide-based biomarkers of the epidermal growth factor receptor (EGFR). Radioisotopes 26-38 epidermal growth factor receptor Homo sapiens 63-95 17979785-0 2007 Cancer molecular imaging: radionuclide-based biomarkers of the epidermal growth factor receptor (EGFR). Radioisotopes 26-38 epidermal growth factor receptor Homo sapiens 97-101 17979785-6 2007 Such EGFR-targeted bioprobes could not only improve patient selection and treatment monitoring, but also allow a direct delivery of radionuclides for radiotherapy. Radioisotopes 132-145 epidermal growth factor receptor Homo sapiens 5-9 16200342-2 2006 Targeting with radionuclide labelled substances that bind specifically to the epidermal growth factor receptor, EGFR, is considered for intracavitary therapy of EGFR-positive glioblastoma multiforme, GBM. Radioisotopes 15-27 epidermal growth factor receptor Homo sapiens 78-110 16200342-2 2006 Targeting with radionuclide labelled substances that bind specifically to the epidermal growth factor receptor, EGFR, is considered for intracavitary therapy of EGFR-positive glioblastoma multiforme, GBM. Radioisotopes 15-27 epidermal growth factor receptor Homo sapiens 112-116 16200342-2 2006 Targeting with radionuclide labelled substances that bind specifically to the epidermal growth factor receptor, EGFR, is considered for intracavitary therapy of EGFR-positive glioblastoma multiforme, GBM. Radioisotopes 15-27 epidermal growth factor receptor Homo sapiens 161-165 11096240-1 2000 OBJECTIVES: Overexpression of the epidermal growth factor receptor (EGFR) has been reported in bladder cancer and is a potential target for therapy with radionuclides. Radioisotopes 153-166 epidermal growth factor receptor Homo sapiens 68-72